ArticleFrontiers in immunology2025

XELOX combined with sintilimab and hyperbaric oxygen therapy for advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase Ib/II clinical trial.

Wenke Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.